arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

PACB
$2.42 ▼ -0.15 (-5.85%) at close
Industrials ·Laboratory Analytical Instruments ·USLaboratory Analytical Instruments
68 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
11
Health
Poor
Bearish
auto_awesome

Analytical Summary

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $751.8M
Dividend Yield —
Revenue Growth -1.9% ↘
Op. Margin -114.4% ↘
ROIC 134.5% ↗
FCF / Share $-0.12 ↗
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$39.01M
↓ -1.9% —
Net Income Profit after all expenses
$-44.74M
↓ -6.7% —
Operating Margin Operating profit as % of sales
-114.4%
↓ -408.8% 0th
FCF / Share Free cash flow per share
$-0.12
↑ +23.4% —
Long-Term Debt Long-term obligations
$896.84M
— 0.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
1
Financial Health ↓
15
Cash Quality ↓
29

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 18 years · 68 quarters